Can-Fite BioPharma Ltd. - American Depositary Receipt (CANF)
Market Open
12 Jun, 13:53
AMEX AMEX Primary $
3. 00
+0.15
+5.2632%
$
1.53M Market Cap
- P/E Ratio
0.68% Div Yield
4,107 Volume
- Eps
$ 2.85
Previous Close Investors:
Want to track CANF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Can-Fite BioPharma Ltd. - American Depositary Receipt (CANF) Statistics
Valuation metrics
Market Cap 1.53M
Enterprise value 7.97B
Trailing P/E (ttm) -778.3
Forward P/E -
PEG ratio -15.73
Price/Sales (ttm) 20,951.26
Price/Book (mrq) 951.64
Enterprise Value/Revenue 20,910.42
Enterprise Value/EBITDA -1,156.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 19.48K
Average volume (90 days) 496.06K
Price summary
52-Week low 2.82
52-Week high 23.4
Beta -
50-Day moving average 3.23
200-Day moving average 4.18
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 5 Jan 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.95%
Operating margin -18.15%
Operational effectiveness
Return on assets -0.72%
Return on equity -1.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.46%
Book value per share (mrq) 0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
